Arcutis Biotherapeutics, Inc.
ARQT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$140 | -$262 | -$311 | -$206 |
| Dep. & Amort. | $3 | $2 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $3 |
| Stock-Based Comp. | $42 | $39 | $33 | $24 |
| Change in WC | -$15 | -$24 | -$10 | $4 |
| Other Non-Cash | -$1 | -$2 | $30 | $0 |
| Operating Cash Flow | -$112 | -$247 | -$258 | -$175 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$23 | -$1 |
| Net Acquisitions | $0 | $0 | $23 | $75 |
| Inv. Purchases | -$255 | -$226 | -$415 | -$293 |
| Inv. Sales/Matur. | $289 | $407 | $351 | $218 |
| Other Inv. Act. | -$5 | $0 | -$23 | -$75 |
| Investing Cash Flow | $29 | $180 | -$87 | -$76 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$100 | $0 | $125 | $74 |
| Stock Issued | $162 | $99 | $176 | $207 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5 | $2 | $1 | $0 |
| Financing Cash Flow | $66 | $101 | $302 | $282 |
| Forex Effect | -$0 | -$0 | $0 | $0 |
| Net Chg. in Cash | -$17 | $34 | -$43 | $31 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $89 | $55 | $98 | $67 |
| End Cash | $72 | $89 | $55 | $98 |
| Free Cash Flow | -$112 | -$247 | -$281 | -$176 |